Bellevue Life Sciences Acquisition Corp. Stock
Equities
BLAC
US0791741087
Investment Holding Companies
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
11 USD | +2.61% | +1.66% | +4.76% |
Financials (USD)
Sales 2022 | - | Sales 2023 | - | Capitalization | 95.08M |
---|---|---|---|---|---|
Net income 2022 | - | Net income 2023 | - | EV / Sales 2022 * | - |
Net Debt 2022 | 1.09M | Net Debt 2023 | 56.58K | EV / Sales 2023 | - |
P/E ratio 2022 * |
-
| P/E ratio 2023 |
210
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 62.64% |
1 day | +1.31% | ||
1 week | +1.66% | ||
Current month | +2.52% | ||
1 month | +2.85% | ||
3 months | +4.17% | ||
6 months | +5.47% | ||
Current year | +4.76% |
Managers | Title | Age | Since |
---|---|---|---|
Guk-Hyun Hwang
CEO | Chief Executive Officer | 48 | 20-02-29 |
Jin Yoo
DFI | Director of Finance/CFO | 50 | 21-08-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Steven Reed
CHM | Chairman | 73 | 23-02-13 |
In-Chul Chung
BRD | Director/Board Member | 60 | 23-02-13 |
Guk-Hyun Hwang
CEO | Chief Executive Officer | 48 | 20-02-29 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-15 | 11 | +2.61% | 105 |
24-05-13 | 10.72 | -1.74% | 4,421 |
24-05-10 | 10.91 | +1.02% | 4,129 |
24-05-09 | 10.8 | -0.18% | 1,044 |
24-05-08 | 10.82 | +1.01% | 3,621 |
Delayed Quote Nasdaq, May 15, 2024 at 09:30 am EDT
More quotes1st Jan change | Capi. | |
---|---|---|
+4.76% | 60.28M | |
+201.71% | 7.3B | |
+2.10% | 982M | |
+41.91% | 872M | |
+25.35% | 799M | |
+1.72% | 661M | |
+5.92% | 653M | |
-.--% | 600M | |
+3.61% | 503M | |
-.--% | 500M |
- Stock Market
- Equities
- BLAC Stock